Risks & the Forward View
What could go wrong — and the questions that decide the next decade
Berkshire's risks are not the usual corporate ones — leverage, liquidity, or a failing core business. They are subtler: size, succession, valuation, and the slow diffusion of the control that has kept it unusually patient.
Key-man transitionSize · cash drag · governance
The bear case is rarely about insolvency — Berkshire is famously over-capitalized. It is that the company is now too large to compound as it once did, sits on cash it struggles to deploy, is led by a new team without Buffett's record, and will gradually lose the concentrated voting control that buffered it[14][8][29].
The main risks
1) Size caps returns. Buffett himself wrote that “companies capable of moving the needle have been endlessly picked over,” and the 2015–2025 underperformance is the evidence[14][13]. A $1T company simply cannot find enough large, cheap opportunities to grow quickly.
2) Cash drag. A record ~$373B in Treasuries earns interest but lags equities; the longer it sits, the more visible the opportunity cost[8][9].
3) Key-man & execution risk. Munger's death, Combs' departure, the CFO's retirement and Buffett “going quiet” concentrate execution on a new team — and the “Buffett premium” in the stock is, by definition, exposed[25][26][28].
4) Governance. As Buffett donates ~$149B of stock, his ~30% voting bloc diffuses, potentially exposing the board to the activist pressure that conglomerates usually attract[29][30].
5) Valuation & substitution. At ~1.4–1.5× book, some analysts argue Berkshire is not cheap and could even warrant a discount to the sum of its parts, while a low-cost index fund is a cheaper way to own diversified equities[44][15].
Three scenarios to weigh (not predictions)
Bull
Abel deploys the cash into one or two large acquisitions and disciplined buybacks, tightens underperforming units, and the culture proves it outlasts the founder. Berkshire re-rates as a durable compounder[5][47].
Base
Berkshire compounds at a solid but unspectacular rate — roughly tracking the market — as size, not skill, sets the ceiling. The cash is deployed slowly; the premium to book holds near its average[32][13].
Bear
The Buffett premium erodes, capital is misallocated without his judgment, governance loosens as voting control diffuses, and Berkshire drifts toward a conglomerate discount[15][29].
Scenarios are possibilities, not weights. Here is where the evidence actually sits today on each decisive question — the lean, the confidence, and the tripwires a reader can check.
The weighing
On whether Berkshire is now too big to outperform: the evidence leans yes (high confidence). The controlling evidence is Buffett's own admission that “companies capable of moving the needle have been endlessly picked over”[14] and the first full decade of trailing the index — ~234% vs ~304% over 2015–2025[13] — which outweighs the 60-year 19.9%-a-year record[10] because that record was compiled when Berkshire was a small fraction of its current ~$1.05T size[31]. The strongest surviving counter-argument: per-share book value still compounded at an estimated ~18.1% over 1965–2025 — the business keeps compounding even when the stock lags[48]. What would flip this reading: a rolling five-year total return back above the S&P 500 at the FY2028 annual report; or a negotiated acquisition large enough (above ~$50B) to show scale can still find scale. Pre-mortem: if this looks wrong in two years, the most likely reason is a market downturn that let the cash buy cheaply and flattered relative returns — or, on the other side, that the lean under-weighted how much of the index's decade was mega-cap tech Berkshire mostly doesn't own.
On whether the record cash is firepower or a problem: the evidence leans drag-so-far (medium confidence). The controlling evidence is the net sale of more than $190B of stock across 2022–2024[53] and Buffett's fruitless hunt for an “elephant” despite record liquidity[43], which outweighs the optionality case because an option left unexercised for three years while the index compounded carries a realized, measurable cost[13]. The strongest surviving counter-argument: Abel deployed $16.8B in his first week and resumed buybacks — the bottleneck may have been Buffett's late-career caution, not the structure[5][24]. What would flip this reading: cash below ~$300B at the FY2026 10-K with underwriting and operating earnings intact; conversely, cash back above ~$400B with buybacks paused again would harden it. Pre-mortem: if this looks wrong in two years, the most likely reason is a 2026–27 drawdown that let Abel run the classic Berkshire playbook at scale — or, on the other side, fast deployment at full prices (Taylor Morrison came at a ~24% premium[5]) that spent the patience without earning its reward.
On whether Berkshire can thrive without Buffett: the evidence leans toward the machine surviving the man (medium confidence). The controlling evidence is $44.5B of operating earnings produced by 60-plus businesses that do not depend on anyone's stock-picking[1][35] and Abel's decisive, Buffett-praised first weeks[5][6], which outweighs the thinned-bench worry because the operating engine, not portfolio genius, now generates most of the value. The strongest surviving counter-argument: the bench genuinely thinned — Munger's death, Combs' exit to JPMorgan, the CFO's retirement[25][26] — and the ~30% voting bloc that shielded the board dissolves as Buffett donates his shares[29][30], so the culture loses its author and its shield in the same decade. What would flip this reading: another principal departure (Jain or Weschler) before the 2027 annual meeting; or a disclosed activist stake as the voting bloc thins. Pre-mortem: if this looks wrong in two years, the most likely reason is that Abel's operator instincts quietly eroded the autonomy that made sellers choose Omaha[47] — or, on the other side, that the lean under-credited how much value a hands-on operator adds by tightening units Buffett left alone.
On whether the machine still has a moat: the evidence leans toward a real but narrower moat (contested confidence). The structural half holds: ~$176B of near-zero-cost float[2] and permanent capital that never forces a sale[37][49] are facts, not narratives, and they outweigh the index-substitution critique on durability because no fund-based rival can replicate them. What deadlocks the other half — deal-sourcing — is that Buffett himself could not land a large deal in his final years despite record liquidity[43], so the evidence cannot distinguish a structurally eroded edge (private-equity auctions, index funds beating Berkshire over 2015–2025[13]) from one that was simply unexercised. The strongest surviving counter-argument: the skeptics' case that the deal-sourcing reputation was personal to Buffett and departs with him[47]. What would flip this reading: a negotiated, non-auction acquisition coming to Omaha under Abel by end-2027 would re-arm the sourcing moat; float falling below $176B through the soft reinsurance cycle[22] would weaken the structural one. Pre-mortem: if this looks wrong in two years, the most likely reason is over-crediting float that a soft cycle quietly shrank — or, on the other side, under-crediting a reputation that turns out to attach to the institution rather than the man.
Each item is sourced in the section above it; see Sources for the full list.